 Fairwealth Securities` 6 investment ideas for CY2012Published on Mon, Jan 02, 2012 at 16:19 | Source : Moneycontrol.com Updated at Mon, Jan 02, 2012 at 16:36 64451 Investors following Axis Bank. Share this News with them.
Fairwealth Securities has come out with its six investment ideas for the year 2012. Axis Bank, Ashok Leyland (AL), Bajaj Electricals (BEL), KPIT Cummins, Jindal Steel and Power (JSPL) and Shasun Pharma are the few portfolio bets for the current year 2012.
Axis Bank : The Bank was promoted jointly by the Administrator of the specified undertaking of the Unit Trust of India (UTI - I), LIC and GIC and other four PSU insurance companies, i.e. National Insurance Company Ltd., The New India Assurance Company Ltd., The Oriental Insurance Company Ltd. and United India Insurance Company Ltd. The Bank has a very wide network of more than 1281 branches (including 169 Service Branches/CPCs as on 31st March, 2011). The Bank has a network of over 6270 ATMs as on 31st March, 2011. The bank is among our preferred picks in the banking sector due to its strong deposit franchise, healthy growth-return profile, and relative discount to peers. Concerns over asset quality of the bank seem largely discounted in the current market price and stock is currently available at a significant discount to its historical average. Currently the stock is trading at 1.7x FY11 P/BV. Hence, we recommend Buy on Axis Bank with medium to long term horizon with the target price of Rs. 1350. Ashok Leyland (AL) : Has seven manufacturing plants - the mother plant at Ennore near Chennai, three plants at Hosur (called Hosur I and Hosur II, along with a Press shop), the assembly plants at Alwar, Bhandara and state-of-the-art facility at Pantnagar. The total covered space at these seven plants exceeds 650,000 sq m and together employs over 11,500 personnel. We expect demand to revive from CY12 with the likely easing of interest rates, thereby helping AL to post robust volume growth in FY13E. At CMP, AL is trading at 9.5x its FY2011 earnings. We recommend BUY with a target price of Rs. 32 for a potential upside of 39%. Bajaj Electricals (BEL) : Is a 72 year old company with diversified business interest in consumer durables, lighting and engineering & projects (E&P). The company has grown strongly with revenues increasing at CAGR of 26% and a staggering 40% CAGR in the bottom line in last five years backed by robust growth in consumer segment and steady growth in other divisions. At the CMP, BEL trades at a P/E and EV/EBIDTA of 9.6x and 5.5x, discounting its FY12E numbers. Based on increasing share of consumer segment, higher cash flows and strong growth prospects, we value the company at 11x FY13E EPS and arrive at a target price of Rs.241. We recommend BUY. KPIT Cummins (KPIT) : Provides technology solutions partner for global Manufacturing corporations with special focus on Automotive, Energy & Utilities, Industrial Equipments, and Semiconductor industries. Highly focused approach has helped company to pioneer innovative solutions and file 37 patents in the Automotive and Semiconductor domains. Following the acquisition of Sparta, KPIT's revenue from its SAP-related ERP services doubled over the past two years. The stock is currently trading at 13.5x FY11P/E which appears to be cheap. We assign BUY rating to the stock with a target price of Rs 185 indicating potential upside of 27% from current levels. Jindal Steel and Power Limited (JSPL) : Is one of India's major steel producers with a significant presence in sectors like Mining, Power Generation and Amidst rising coal supply insecurity in India, the company stands out as one of the few companies having captive coal resources. We believe the integrated status of the company ensures it would generate better returns than the regulated players in the power segment. The sock is currently trading at very attractive valuations of 11.3xFY11P/E. We recommend BUY with a target price of Rs 640 which is a price appreciation of 41% from CMP. Shasun Pharma : Is engaged in manufacturing active pharmaceutical ingredients (APIs), their intermediates and enteric coating excipients with a significant presence in some key generics. Shasun has created a strong product portfolio, building on its R & D Expertise, regulatory capabilities and multi scale production capacities. Today, Shasun is one of the largest producers of Ibuprofen worldwide. The company offers derivatives of Ibuprofen like Ibuprofen Sodium, Ibuprofen Lysinate and S+Ibuprofen. It is also one of the major producers of Ranitidine and Nizatidine in the world. Its products are exported to countries across North America, Europe, Asia and Latin America. The stock has come under pressure due to steep rupee depreciation which would lead to Market to market losses on company's forward contract We believe going forward the company is a candidate for re-rating due to high potential growth with majority of earning accruing from UK subsidiary. At the CMP the stock is trading at 8.4x for FY11P/E. We recommend BUY with a target price of Rs 90. Shares held by Central Governments/State Governments Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions. To read the full report click on the attachment Attachments : Investment-Ideas-2012_Fairwealth_020112.pdf
PREVIOUS STORY Trending NewsBusiness News
|
News MS Sahoo Says On CNBC-TV18 New Guidelines Are An Improvement Over The Old Ones  The latest earning numbers FIRST on CNBC-TV18
Videos
May 29 2012, 12:19 Expect Tata Motors Q4 PAT at Rs 4200 cr: StanChart - in Brokerage Results Estimates Interviews
 May 29 2012, 22:37 | Source: CNBC-TV18  May 29 2012, 17:34 | Source: CNBC-TV18  Subscribe to Moneycontrol Newsletters |
|||||||||||||||||||||||||||
